Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U1111-1120-5710 | Other Identifier | WHO |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in India. Perceptions and practices of physicians and subjects about diabetes management will also be evaluated.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment given | Other | Patients will fill out a questionaire by interview. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean age of onset of type 1 diabetes mellitus | Evaluation visit | |
| Mean age of onset of type 2 diabetes mellitus | Evaluation visit | |
| Mean duration of treatment of type 2 diabetes mellitus | Evaluation visit | |
| Percentage of patients on Insulin therapy | Evaluation visit | |
| Percentage of patients on Oral Anti-Diabetics Drug (OADs) therapy | Evaluation visit | |
| Mean duration of diabetes in type 1 patients | Evaluation visit | |
| Mean duration of diabetes in type 2 patients | Evaluation visit | |
| Mean FPG (fasting plasma glucose) | Evaluation visit | |
| PPG (post prandial glucose) | Evaluation visit | |
| HbA1c (Glycosylated Haemoglobin) | Evaluation visit | |
| Percentage of patients archiving HbA1c target below or equal 6.5% | Evaluation visit |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients with diabetes mellitus (both type 1 and type 2) being treated at general hospitals, diabetes clinics and referral clinics will be selected according to inclusion and exclusion criteria.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Bangalore | 560001 | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24944934 | Result | Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, Banerjee S, Wangnoo SK, Kumar A, Kalra S, Unnikrishnan AG, Sharma SK, Rao PV, Akhtar S, Shetty RV, Das AK; DiabCare India 2011 Study Group. Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study. Indian J Endocrinol Metab. 2014 May;18(3):370-8. doi: 10.4103/2230-8210.129715. |
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D003922 | Diabetes Mellitus, Type 1 |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Percentage of patients archiving HbA1c target below or equal 7.0% | Evaluation visit |
| Percentage of patients having complications (dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications) | Evaluation visit |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |